Thyroid carcinoma (TC) is a prevalent malignancy of the endocrine system, with a notable
rise in its detection rate in recent decades. The primary therapeutic approaches for TC now …

Thyroid cancer is the most frequent endocrine malignancy, with more than 500,000 cases
per year worldwide. Differentiated thyroid cancers are the most common forms with best …

Thyroid cancers developed from the tissues of the thyroid gland are classified into papillary
(PTC), follicular (FTC), medullary (MTC), and anaplastic thyroid cancer (ATC). Although …

Purpose In the search for novel effective compounds to use in thyroid cancer (TC)
unresponsive to current treatment, attention has recently focused on plant-derived …

Papillary thyroid carcinoma (PTC) is the most common subtype of differentiated thyroid
cancers in Asian coastal cities, where the patients have increased risk of potentially high or …

Thyroid cancer, particularly undifferentiated tumors, poses a significant challenge due to its
limited response to standard therapies. The incidence of thyroid cancer, predominantly …

Editorial in preclinical and Phase II clinical trials. In laboratory studies, TZDs have been
observed to inhibit cellular proliferation by causing cell cycle arrest and apoptosis. These …

Thyroid cancer (TC) and thyroid autoimmune disorders (AITD) are among the most common
diseases in the general population, with higher incidence in women. Chronic inflammation …

Background Thyroid cancer, as with other types of cancer, is dependent on angiogenesis for
its continued growth and development. Interestingly, estrogen has been shown to contribute …

Anaplastic thyroid cancer (ATC) is an aggressive and lethal malignancy having a dismal
prognosis. Phytochemicals are bioactive components obtained from plants that have been …